Masaki Tohyama
- Infectious Diseases top 5%
- Antifungal resistance and susceptibility 4
- Tuberculosis Research and Epidemiology 2
- Epidemiology top 10%
- Fungal Infections and Studies 10
- Nail Diseases and Treatments 2
-
- Toxin Mechanisms and Immunotoxins 4
- Parasitology top 10%
-
- Antimicrobial Peptides and Activities 3
-
- Bioactive Compounds and Antitumor Agents 3
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 2
Masaki Tohyama
19 papers receiving 622 citations
Peers
Comparison fields: 5 of 64
- Infectious Diseases 325
- Epidemiology 469
- Immunology 181
- Parasitology 54
- Microbiology 29
Countries citing papers authored by Masaki Tohyama
This map shows the geographic impact of Masaki Tohyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masaki Tohyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masaki Tohyama more than expected).
Fields of papers citing papers by Masaki Tohyama
This network shows the impact of papers produced by Masaki Tohyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masaki Tohyama. The network helps show where Masaki Tohyama may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Masaki Tohyama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | [A case of drug-induced pneumonitis due to levofloxacin and kampo medicine]. | 2006 | 2 |
| 2 | 2002 | 3 | |
| 3 | [A case of loxoprofen-induced pneumonitis pathologically resembling hypersensitivity pneumonitis]. | 2002 | 2 |
| 4 | [A case of pulmonary infection caused by Mycobacterium szulgai]. | 2002 | 1 |
| 5 | 2001 | 0 | |
| 6 | 2001 | 41 | |
| 7 | 2001 | 47 | |
| 8 | 1999 | 18 | |
| 9 | 1997 | 98 | |
| 10 | 1996 | 2 | |
| 11 | 1996 | 5 | |
| 12 | 1996 | 43 | |
| 13 | 1996 | 71 | |
| 14 | 1996 | 74 | |
| 15 | 1996 | 28 | |
| 16 | 1996 | 121 | |
| 17 | 1996 | 3 | |
| 18 | 1995 | 9 | |
| 19 | 1995 | 54 | |
| 20 | [A therapeutic trial of experimental tuberculosis with gamma-interferon in an immunocompromised mouse model]. | 1994 | 7 |
About Masaki Tohyama
Masaki Tohyama is a scholar working on Toxicology, Microbiology and Epidemiology, having authored 20 papers that have together received 629 indexed citations. Recurring topics across this work include Fungal Infections and Studies (10 papers), Antifungal resistance and susceptibility (4 papers), Toxin Mechanisms and Immunotoxins (4 papers), Bioactive Compounds and Antitumor Agents (3 papers), Antimicrobial Peptides and Activities (3 papers), Tuberculosis Research and Epidemiology (2 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (2 papers) and Nail Diseases and Treatments (2 papers). The work is most often cited by research in Infectious Diseases (325 citations), Epidemiology (469 citations) and Immunology (181 citations). Masaki Tohyama has collaborated with scholars based in Japan. Frequent co-authors include Atsushi Saitô, Kazuyoshi Kawakami, Qifeng Xie, Qiang-min Xie, Norifumi Kudeken, K Kawakami, Katsuji Teruya, Kazuyoshi Kawakami, Mahboob Qureshi and Satomi Yara. Their work appears in journals such as Clinical & Experimental Immunology, Infection and Immunity, Antimicrobial Agents and Chemotherapy, Immunology Letters and Kansenshogaku zasshi.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.